While some studies show that DCIS does not respond to NAC [14], others suggest that DCIS components might completely be eradicated after NAC, notably in HER2-positive tumors [15,16], and that there exists a strong correlation between invasive and non-invasive components in terms of pCR [17]. The gene discussed is ERBB2; the disease is ductal breast carcinoma in situ.